Holmstrom
`
`U.S. PATENTS
`
`
`
`Examiner|Cite|Patent Kind|Issue Date Nameof Patentee or Pages, Columns, Lines where Relevant
`
`
`
`Initial |Number|CodeNo. Applicant of cited Passagesor Relevant Figures Appear
`
`Document
`[|oaosaeaa[|2006-70-20|Rowiandson
`pafaso2e2e[1971-08-31|Herndon Richare A
`[____}3__fas08720
`Haselden
`
`-4f069878 Marantz
`/___}5_fs669880
`Marantz
`CO Marantz
`eSa Scott, A
`CO Marantz
`
`PpJaFao0085 Eaton
`faa
`Johnson
`piaaa
`Markowitz
`fefassic0e
`Boucher
`PFsFaas
`Thompson
`
`preFass6065 Thompson
`ACc
`Nason
`piefasta
`Ash
`irFa0s0587
`Polak
`refas70c08
`Mason
`Fis[2685503
`Gabie
`ESEOCi
`King
`eSeeCe
`Rober ADuFaik
`Yafaa20663
`Albert
`Cc
`Lindsay
`Voss ee
`r992.01-14
`a
`DobosHardy ee
`992.08-03
`Coiman
`992-03-17
`fa6fs0sri23
`Wyborny
`992-07-07
`eSa
`Beltz
`994-02-08
`Yee[528070
`Meidl
`994-04-12
`eS
`994-04-26
`Zacouto
`ee
`[0 [5208745
`994-06-07
`Lascombes
`
`>Fifa 760 ee
`995-11-21
`Goddard
`aEeEe
`997-11-04
`Goedeke
`|___|sa__[508342
`998-06-09
`Kenley
`[faa[oren7e2|
`998-10-06
`Ziad F. Elghazzawi
`P855819007
`a
`999-08-31
`Roberts
`1999-11-16
`Klein
`id5987352
`2000-04-11
`Anslyn
`p886048732
`Holmst’om
`|____|3o__[eos2622
`King
`P406058331
`Dulin
`ptf6230059
`Maberg
`|____faa[e2as0e3
`Treu
`Pid6254567
`aCe
`Moberg
`|_—*as_fesesor
`Ben-Haim
`aCe
`Piafessaro8||2008-04-20|Mann
`|___[as[esssoss|__|2003-0429|Mobera
`Pidfesec229||2008-07-08[Connelly
`pCOfesozs99|2008-08-05[Fromherz
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`aa-
`
`aP
`
`Page 1/11
`
`INFORMATION DISCLOSURE.
`
`[Filing pate
`
`2019-05-14
`
`Application Number
`
`16411508
`
`
`
`
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`

`

`INFORMATION DISCLOSURE.
`
`[Filing pate
`
`2019-05-14
`
`Application Number
`
`16411508
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`|C00012299US01DIV(MED-2910 [S«*dST—«sfeeosoesdTSSC«dOURO—SC«C*[DavidRRFischel
`
`=—OC—“—*“—*~sdSCi‘“‘CSOCSCOOOOOCOC~C~CS
`pC‘Ssfea7igs|2003-09-30Wong
`pC=*'SSSsfe76s08|2004-01-13Keren
`
`
`PS«safeviiase[2000-23[Bradley—C—“—*~—s*~*—C—‘—‘—‘“‘YSSCSCSC‘C;~C~C~C~;~;CS;S;7;7;<OC
`PpC“‘z§SSSfesisigg[2004-11-16Wong
`pC*'SSSsfss7g283|2005-04-12|Thompson|
`PS«*d7__eseoi7a[ious101~—S——s‘sGra—CSC~—sSSCCCCCCOC™C™COCOCOCCCCCCCCC‘“(‘#(NCC*di
`PpC=‘“'SCfor7sio|2006-07-18Golda
`[S«*9‘[veosose[C[p00r-042eCMichehSSC—C“—*~“—“C*‘“—‘—‘—‘dTSC“‘<‘<(2S;SSSSSSTTTTTTTTTTTTTTCd
`Peo[7276042|‘ 2007-10-02 Se
`pC‘,=7404799|i2008-07-29SteveKon
`PC‘566432|2009-07-28Wong
`
`
`PSC«*des=orec6ea|C«00o-08-18«Childers—SC~—“*‘“*dSC“‘(CSSOCOCOOOOOOCOC‘“‘CSNCO#@C
`PptC“‘icAizetoose|2009-10-27,ChunleiKe
`[C«*deSveraest[s[eoroos-09————C‘iMCCOBESC—=~“‘“‘C®CNNNSCN#NSCiédS#Y#RYyANNNNNNNNNNNNSWw“=Ssi‘D)iz
`Pee[7r0asei[00-04-27 a
`PpC*G?_s773507|00-06-15Wong
`PCi*dSS7548520|00-07-13Burnett
`[feo[r7sesva[izoroorigCdARDSCOC~—“—~SSCsSSCSOCOC™C™OOCOCCCC(N.CCS
`pCi777ezio|2010-08-17,[Rosenbaum
`Poggi|00-09-14Perry
`pre[vases[iato-ia-iaiPoaschegg——SSCSC~—“—~—“‘~‘“‘(MSC‘;SCCCCCCCCOC
`PoCi=d367214|0totChiiders
`PCA922086|01-04-12Childers|
`«dSfreazott[szit-oai2[Micheh—“—*~—*s—s—‘“‘—‘iTSC“‘<‘<2CS;SCSSSSTTTTTTTTTTTTTTCd
`pCi‘947179|2011-05-24[Rosenbaum
`Pd9e7022|0t06-28Grant
`PS«d8—~‘vepiose[Csfoteov-i9sangCSC~dSC“(‘CSSTTTC~SCSY
`PpCi‘iQDSf8034it|0Gara
`pC*BO*BOVO709|01-12-06Chiiders|
`
`PSC«*d8—‘[soseses[CiteOr-i7_—S—=éiRobertsSC“‘“*S*dSC“‘(CNNNNCN”CNCNO”NC®NOC”CNCNCNNCOC(N‘NNCCO'd
`pC‘8183046T201205-220tT
`PC*SS*8187250|2012-05-29[Roberts|
`Pps«eafezaszs[Ci[zoizoe-2isiwitsC—“—*~“—s*s~s—‘—‘“‘“‘;‘iYSC“‘<‘<;<2C;7;7;7;3SPStStSSSTTTTTTTTTTCd
`PpC‘“(S'SS8273049|201209-25[Demers
`PC‘“BGSsB2O2594|0210-23Tracey
`farasisess[iaoiestizofuC—O|SCOCOCCO....C.CCCOCTTTTCTTCCCSY
`PpC=‘“‘SBt7492T201211-27[Demers
`PpC*B8B571IS|01-01-22Childers|
`
`
`|sC*f90—faaeeste—[C*[zis-oz05[Kamen—C—“—~—s—s—s—s—s‘iTSSTCTCCCCOCOCOC™~™COCCC*d'
`
`pCi‘assess|C[z0rs0205Kamen—OC—C“—s~“CSC—‘SC“‘C;‘C;CS;SSCOCOCCVCCCCC‘C(‘d’
`PpCid8409447|201304-02Wie
`|s*f93feaoevso[Ci[zviossos——iwitsSC—“—*~“—s*s*s*—“‘“‘;C‘*dTYSC“‘(CSSTTCTCTTTTTTTTTTTTTTC~™Y
`PpC‘iCS=fts2600|2013-08-27,[Raimann
`pCi85355250|2013-09-17,[Heyes
`P«d96—isseori2[iorsiaspySSC—“*‘“—*dSC“‘SNSCCCOOOOCOC#ON”CO#(‘(N’NNNNN.CC#d
`PpCiéi'9s8597227—|20138-1203Childers
`ptC“‘&N=[BCQ6826——|201404-15Kirsch
`
`
`|séfg9fevosae2[C[z0iaizo2i[Soykan—C—“—*—“—s—*~*s~*—C—‘“‘TSC‘;SSCSSTTTTTTTTTTTTTTTC*™Y
`
`|Ss«éfooosoaess|C[z0re-07-26Nanas;—CSC~C“—*‘“S*s*dC“‘C;S;SSSOOUUUUUUUUUUUTTCC~*Y
`
`
`
`
`
`Attorney Docket Number
`
`Examiner
`Initial
`
`Page 2/11
`
`

`

`INFORMATION DISCLOSURE.
`
`[Filing pate
`
`2019-05-14
`
`Application Number
`
`16411508
`
`pAf20too084330—|2010-04-08[Wong
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`
`PocketaRniAga|CoooT aseUSEHOIPREDESire|
`
`
`Cite|Publication Kind|Publicati Nats Ba iri re
`
`
`
`
`||rrrr—“—~isé—sdCSC“‘(‘“tCDocumentsdPo Figures Appear
`
`P«d_Ronaooaser«ida0TT Schulman TOCSY
`Pf20020712609|i2002-08-22|Wong PO
`|C3[20030080059|2008-05-01|Peterson PO
`
`|___|4_[Poosoos7oss—«|~——=«*dta0s-06-22—_—‘|Gura TOOOOCC~*Y
`PS20030105435|2008-06-05|Taylor PO
`PG20030114787|2008-06-19 Gurra PO
`Pir_fonaorarars[=i2003-10-02__Tranthong CS
`PB20040019812|2004-01-20|Childers PO
`)[20040099593|2004-05-27,[DePaois,|
`
`fiof0oora7s00i——S—«d200a-07-20——=*Polaschegg—SSSCSC~—~—SCSCSsYSCCSSSSCSCSCSCSCSCSSTTTTC_~Y
`pt[20040215090|2004-10-28Erkela
`p12[20050065760|2005-03-24[Murtfelgt
`Pp|18feoosoris7e6«|~——«dvaoos.05:26——=«dttayor~—SSSC~—SCSSC‘C~SC~‘dSC‘“‘~‘;C;S;S;SSSCSCTCC*d
`pid4[20050126961|2005-06-16[Bisse
`pS[20050126098|2005-07-16[Childers
`
`Pp[16fPo0sotsosse«|~——~SC=«*diBOOSO7-14——~«diTsukamoto—SSSCSC~—SC—CS|SSSSCSCSCSCSSTTCCCC‘;«‘*Y
`Pid720050284354|2005-10-20[Rowiandson|
`P——=«dtSfe0osoesase7«|~—=C=«idiOOS0-20—=édioeiXue—SSCSCSC~—SCSSSSSTTTCCCOCOCOCOCOC*d
`P18fPoosossass1«|~—=~=«idi0St0-20—~—~=«dNiemetz——SSOSC~—SCSSSSSSSCCCCSC~CSOSOCOCCCC;C~C;~C~CSY
`P2020050274658|2005-12-15[Rosenbaum
`
`)«220060025661|2006-02-02[Sweeney|
`Pp[22[poosors5064«|~——=«diooBOsST—=«diPlaney—SSSOSC~—C—CSSSC“C~C~‘iTSCSSCSCSCSCSCSCSCSSTT..CCC‘C;(C*d
`Piesfeooozi777i«|~——«*dzaooe02-28«|SoykanSSCSSCCCCSCSCOCOCOCCC~*Y
`|«2A20060226079|2006-10-12[Mori
`isfeoneo2si708«i—SC=«id20S0-26CiSoyaSCSC~—SCSSCSPSCSCOCSCSCSOCOCOCCCCSY
`
`
`
`|_____28[20080247548—=«idrBoos.17-02_—*|ShantanuSamar———SSCSC~—“‘—*~C~*~iSC“‘;SSCCCCCCCCCCCOC™~CSCCSY
`p27[20060264804|2006-11-23[Moberg|
`
`[28|2o07oco7a08——[——S—=«dBorTT——=CédiBrger—SSSCSC~—~—“‘—‘—‘—C—*—C—C—‘—‘—‘—‘(YSSCSCSCSCSCSCSCSCSSTCC.CCCC‘(StCC*d
`[28|eoovocsaiss«|——~—=«diOoo1S——iiJongGin.——SSSCSC~—CSCSCSCSCSC|SSCS
`[___|[s0_|2007ocess28|——~‘jaoo7-0s22—itannoy—SSSOSCSC—SCSSSC|SSOCSCSCCCCCSCSCSCSCSCSCY
`
`
`Piafaoovorseorsi—=«d2007-06-21«HofmannSSCSC~—SCSCSSCSSSSCSCSCSCSCOCOCCCCCSY
`P82[20070175827|2007-08-02[Warr
`
`p8320070170431|2007-08-02[Roberts|
`P[a4feoororisas|—‘(|ao07-0920—~iBissler——SSSCSC~—“—~S*S*CC‘“‘~‘dYSC“‘“‘;7C;CSSSSSTSCSTSTTTTTTTTC*d
`P85[20070255250|2007-11-01[Moberg
`p8820070276270|2007-11-20[BaoTran
`|_____|s7__}P008oc08s70_—+|—*‘jaoosorto.—sdGuwas—Cs=~=~“*~*~*—‘“‘~*S*S*~*idSC“‘(SSSCCCCCCCTTTTCCTC~CS
`[ssfeoosooaiss7———s[——SC«*diBoeSCSCSCSCSCSCSCSOCCCSOOOOCCSCS
`)C8920080053905,|2008-03-06[Bugger
`P[40|2o0aoceris2_—[—=*20-020—i[RossSCSC~CSCSCSSSCOCOCOSOOCOCCCCSCSCSC“‘“CSC*S
`pA20080215247|2008-00-04[TONELLN
`p42[20090020471|2009-01-22[Tsukamoto
`
`
`[____|43[eoosorors77__—«|~———~+djaooe-0423—=*«(FULKERSONSCS]SSSSSCSCSCSCSCSC.CCCC‘(SCNC*d
`pidAA[20090124869|2009-05-14[WeiChinHU
`p4520090127193|2009-05-21[Updyke
`iesfonsca7seas«|SSC*daost-05—SC=«dSTEWAAT.OOC~C—CSSCCSCSCSCSCSOCOCOCCCSCSC‘CSC~C*@Y
`Pid?20090275883|2009-11-05[Chapman
`p48[20090281484|2009-11-12[Childers
`
`[____|4s[eoosoaazes0«|~—~S=«idtBoost1g—S—=idGas—SSCS*~—“~*~*~*—*—‘“‘“‘—‘~‘SC~C‘“‘;zdYSSSTTCCTCOCOCOCOCC*d
`[so|2oro0ceases|——S=*dTOTO?——sidtven——SSCSCSCSCSCSCSCSCSCSC|SCS
`PSA[20100010420|2010-01-14[Childers
`[____|[s2__|2o1o007assi__——=«|~—=«idiOTO-mOT——«d(Merchant——SSSSCSC~—SCSCSSCS|SCCSCSCSCSCSCTCCC‘(CS~C*d
`pdf20t0007ese7_|2070-04-01Wong
`
`Page 3/11
`
`

`

`INFORMATION DISCLOSURE.
`
`[Filing pate
`
`2019-05-14
`
`Application Number
`
`16411508
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`[puma———SCSCSCSCSCSCC|SSSSSSCSCSCSCOCSCSCSCSSC
`
`[ssfaorooosatssidoSC*dSOUEMOOCSC~C—C—CCSSSCSSSCSSSOSOCOCOCOCOCCCSCSCSCSCS
`P_Ys6faaroorr4012|__|2070-08:06|Sandiord————SSSSCSCSCdSS
`[__|s7__[aotooiarees____[[2010-0603|PORRAS—SSSCSCSCSCS|SSSSSSSCSCSCSCCCCSC~CSY
`|__|faotooressas|__[2010-0701KamanSSCS]SSSCSCSCSCSOCCCSCSCSSY
`[|efaotooat7iat____|_|2010-08-25|Robers——S—SCSCSCSCSCS|SSSSSSSSSSSSOSOSCSSSCC~*Y
`[feof2orooa2aaez|__[20i0-000[dng————SSSSSCSCSC~dSSSSCSSCC~S
`|____Teifaotooasa7es__[__[aoi0-0s-16___|WallenasSSCSSSSSCSCSCSCSCSCCC~C~*Y
`PJfaotoaacioas|__|200-0923_|KelySSCS|
`
`
`[____}es__feotioor7e6s|___[20ir-07-27___[UseykoSSCS|SSSSSSCSCSCSOSC~CSSY
`[Teaf2otio066006__[__[aoitosi7___[MatiBanetSCSSSCSCSCSCSCOCCCC~*‘*d
`[Jesfaotiooes0as[=iz0rtoai7—paneT.SSCSSSS
`P____fes__faotioorrera[|—ifzoioaat‘sagSSCS|SSCSCCS
`
`
`|_____Jerfaorioo7esss|__[aoitoao7[RaimaSSCSSSCSCSCSCOCC~*Y
`[Jesfaotioosria7—_[—ifzortoaia|BeckSSCS|SSCS
`
`[___|es_faotioia0ess|__[aoi-0602[DongSSCS|SOSSCSSOCSC~*S
`
`
`[frofaorioisrise____[___[20i-0609|PeterKotanko.SC‘SSSCSCSCSCSCOCC~*d
`
`ifeorioraitie|z0rt-06-16|DaleschSSCS|SSS
`refaorioreasaoif=ieoro72eidanSSCS|SSSSSSOSSOCCSCCSC—SY
`[rsfaotioaress7———[—izoitioramSSS]SSCS
`
`Pefrorioaoiaay—z0rtteosPARKSSCS
`
`[fasfaotioaoiera|__[20i-t208|TobiasGober——SSSSCSC~iSSSSSSSCSCSCSCSCSOCC~*d
`[rsfanreootezes[CioranSSCSSSCS
`
`[77faota008s720[202-0405|cniaersSSCSSSC
`
`[|vfaoraooas7o7___[___[aoiz0a12|BerigerSSCSSSSSSCSCSCSCC~*Y
`
`[frefaotaortseas[=i202-0510—‘AnsyinSSCS|SSSCSCSOSOCSCS~SY
`[|faor20a20528|__|2072-08-30|Vanantwerp_—SSSSSSSCSCdYSr
`[_____|ai__Jaoraoasssas[|__[aoiato-1___[MARRANSSCSSSCC*Y
`[faefaotaoaraasa[=iaoiettot‘OmanSSCSSSCS
`
`PJsfaoraoaraais[=izoitot___|Gerber_——SSSSCSCSCSCSCS|SSS
`[|efaoraoaraazo|__aoiatot____|GereerSSCS|SSSSSOSOSCSSOCCSCSCSCY
`[fasfeotaoarreas[|——~dfaoietrot|SoykanSSCS]SSSSSSSCSCSCSCSCOCCSCSCSCSY
`
`[Jasfaotazoarrese[=iz0atot|GerberSSCSSSCS
`[__|a7__feotaoarreoa_[__aoiatot____|GereerSSCS|SSSSSCSSOSCCCCSCSCY
`[Tasfaoteoarreso|_aoietrot___|Gerer—SSSSCSCSCSCSCS|SSCS
`[Jasfaoraoaress|__—faoiatot___|Gerber——SSSSCSCSCSCSCSCS|SSS
`[_____|0_faotzoarzree|__aoiatot____|GererSSCS|SSSSSSCSOCCCCCSCSCSCY
`SnTo
`
`
`[2faoraoacsa7e|__|2012-11-20|DeepaMahajanSdSS
`
`[____]es__faorsoos7aes|__[aoisczia__|HeyesSSCSSSCSC~*Y
`[faafaotsortesrs|__avisos00—*4fdianSSCS|SSSSCSCSCSCOCCCCCSCSCSCSY
`P____}es__f2oraoieee98|__|2013-08-08__|Kely———SSSCSCSCSCS|
`[es__f2orsoatasoo__|__[20ia0a-22_|kelySCC|SSSSCSCSCSOCCSCSCSCSC
`|_____}er__Jaotsoaraeae|__avisto-i7___|SoykanSSCS|SSSCSCSCSCSCOCCCSCSCSCS
`PJsfaorsoazaeis|__|2013-1205|(KrenstyBrton———SSSSd|SS
`[|efaorsoaaoz0s___f_—iavistai2idlySSSSSSSCSCSC~dSSSSSSSSCSOOCCCCCCCSCSCSC
`
`
`[ioefaotsossiza|——idaoistai2idan’SSCS|SSCS
`
`[fierfaotaoorares[i20ia-o-i6|Pianey_SSCS|SSS
`
`[ioefaoraooaa0e2|___[a0ia-oata[AkonSSCS|SSSSSSSOSCSCCSC—S
`
`
`[fosf2oraooese50|__|204-0306[MendelsohnSSCSSSSCSCSCSCSCOCC~*d
`[fiesfaoraooesaaa|__[20-03-27|Soykan———SCSCSCSCSCS|SS
`[fiesfaoraorvoaao__|__[aoia-oa2a[whiteSSCS|SSSSOSCSCSCSCSCSC~CSY
`
`[fosfaoraortosat[|—iavi-oaeewhiteSSCS|SSCCCC
`P_fiorfaoraoreasas|——izoia-os-t2coeSSCS|SSSSSSSSSCSCSCSCCCSCSCSC
`[iosfaoraorsases|___[oiaoei2
`
`
`
`
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`Page 4/11
`
`

`

`INFORMATION DISCLOSURE.
`
`[Filing pate
`
`2019-05-14
`
`Application Number
`
`16411508
`
`
`
`
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`
`
`[reseoraoreseesiCCidTTCdPUSSSC“‘“SCSCSCSCSC‘sNSTCNNNN.NSW-/-§-—SS
`
`Frito20raoieoars|faora.o7-10_|Meyer
`risJaoraoar7o2s|__faoraos-c7[PugSSCSSCS
`
`[frieJaoraoat7os0__[___—poreos-o7[MeyerSSCSSSSSSSSCSCSOSCSCSCSCSSSSCSY
`
`Fis|20raozz0cee—[__faora-o8-o7[PutSSS
`PreYaorsoiaasae__[__faors.os-28_[pube———SSCSCSCSCSCSS|SSCSSY
`[fis|aorsoveace7|_—s2ots.0s-28[vonbumes—SCSC~—~—SCSCSSCS
`
`Fries20750149096|__|2018.05-28|OmanSayanSSS
`
`[Firs2002076550[|None__|SweeneySS
`
`
`[Fis20050026089[|None_‘|GaleySCS
`[Fisus20080060467[|None[HeySSS
`
`[Fao]useo0eoreras0a7||2006.08-37|AntonioBoseto__——S~S—S
`
`[rat[useortoorrs7sai_|__[20v7-03-s1____|Matthias——SSS—=SKraemer
`
`
`prsusaoizoz7sasaai|_[porait-o1|SoykanOman__——SSSS——S
`[Fras[usaoreocasae7|Jaore0z0a[smnSS
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`
`
`
`
`
`
`FOREIGN PATENT DOCUMENTS
`
`
`
`
`Examiner|Cite|Foreign Doc. |Kind|Publicaiton Nameof Patentee or|Pages, Columns, LinesCountry
`
`Initial No.|Number Code|DateCode
`
`
`Applicant of cited
`where Relevant Passages or
`Document
`Relevant Figures Appear
`Pfoosreaswo2000-70-05[GambrolundiaBOTCSCSC~C~iwrN_—CS
`PSC«*d2~—sfosoaeastEPC«d~SSSCSC«*d‘00-0R-DBCdSLudeMedicalABTSSCSC~“*~*~*~*~*~*dCN_C
`
`
`P«S—Citoriosee7SCNS«~S=«*d08-06-04=NikkisoCompanyLimited|SSSCSCSC~*dC_
`
`
`
`
`[aaasesestERS«*2073-03-20[RenalSolutions,inc[SSCS
`
`
`
`PpC*dSCitaeaseeatEPCSSC003-26CdPhilipsJapan,ttd|CSCSC~C“‘“*~*~*~*~*dCN_—CX’
`
`
`
`PpC«dS«iaaoaesa(WOS|=«*d2074-05-07=iBaxterinternational,nc.|SSSSSCSCSC~dCN_
`
`
`
`
`[iraoensswo«=207405-07[BaxterInternational,ne.[SSSCSCSC~C~S~SCSC~SFN_
`
`
`
`
`PC«dSCiaaor7oezC(WOSdTSSSS=«*d2074-05-22[Baxterinternational,nc.[|SSCSCSCSC~C~CSCSC~dFC
`
`
`po5os7oTEPTf2008-10-15[GambrolundaAB|to
`
`
`
`[fioisezaeastERCC«*2009-06-24[NStageMedicalne.[SCSC~—SCSCSF_
`
`
`
`
`PSC*dtT—~*oooeete7at[WOTSSS«d000-090—i«dBisslerSSC“sé‘“RSC“‘(S)S;COOOOOOUOUOCOCCC#«4@SO
`
`
`
`PpS«d2—*oovoaszesae[WO«|~——S=«*t2007-09-27=Hemocleanse,Inc.|SSCC«d(O_C
`
`
`
`[fsYeoorvosovat[WO=«*2007-09-27[Minimed,inc.CidCSCSC™~SCSCSCSCSCS
`
`
`
`
`
`pA[200304867702[WO|2008-05-30[NationalQualityCare,Inc§[to
`
`
`pS[2003048680[WOU|2008-05-30[GambrolundaAb|to
`
`
`
`
`[fieYoososta2zzn2[woS—«*di2003-06-26[NationalQualityCare,inc.[SSSCSCSC~SCS~SF_
`17
`2004008826
`WO
`2004-01-29
`Baxter InternationalInc.,
`no
`
`18
`
`2004009156
`
`WO
`
`2004-01-29
`
`Baxter InternationalInc.,
`
`no
`
`
`
`peeferncioreawsaff
`pee[emtittaneaosa,||”
`
`
`[__—~*iis_[2coaosorieaa«(WO|___|a0040475_[insuletCorporation‘|——S—SCSCSCSCSCSCSCSCSF_
`
`
`
`
`
`[___‘[20_feooaosorivaz«WO«|~—SC=«*di00OHTS|insuletCorporation[|————S—SSSCSCSCSCSCSCSCSC~SFO
`[__]2i__|2ooaoeaeteaa [WO|| 2004-08-05|National Quality Care, me[|——=—S—SCSCSCSCSCSCSCS—SFo_
`
`
`
`
`[____]22[aoosi2saa0a2__|WO_|| 2005-12:20 [Renal Solutions, Ino. [|ne_
`23
`2007089855A2
`WO
`2007-08-09
`The Regents Of The
`no
`University Of California, U.S.
`Government: Department Of
`Veterans Affairs
`Zentrum Fur
`Biomedizinische
`Technologie Der
`Donau-Universitt Krems
`
`
`
`24
`
`2009026603
`
`WO
`
`2008-12-31
`
`
`
`no
`
`Page 5/11
`
`

`

`
`
`
`
`
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`25
`
`2009026603A1
`
`WO
`
`2009-03-05
`
`
`
`no
`
`
`
`Zentrum Fur
`Biomedizinische
`Technologie Der
`Donau-Universitt Krems
`
`
`P282009157877A1twoTd2009-12-30TemasekPolytechnic|to
`
`p272009157878A1_[WO|2009-12-30|TemasekPolytechnic|tt
`P28[2oro0zaseo———=S«dWO«|—~—S~=*di0TO-0S18—~[BBraunAvitumAg|
`S/53
`|«29[201002886081[WO 2010-08-18
`30
`201 1025705A1
`WO
`201 1-03-03
`Baxter International Inc
`
`eee
`
`° 0 0
`
`5 n S
`
`[iat[aoraoar7sstWO—* pei|SS—~™Y
`
`P|s2__| 201a1aa7er
`Bore11-01
`eS 2012-12-20
`0
`faa [2072148786
`Bore11-01
`no
`
`p85|2012148789 2012-11-01
`no
`36
`2012162515A2
`WO
`2012-11-29
`Deka Products Limited
`Partnership
`5°
`rsd87|2012172398 2012-12-20 Gambro Lundia Ab
`
`
`2013-02-07
`Baxter International Inc.,
`Baxter Healthcare S.A.
`
`y/5];5oO]/OToO
`
`2018-02-07
`[__[s8___[z07a07908a02
`5°
`2013-02-21
`|___[ao [20%s0258a4
`2013-02-28
`Medtronic,
`Inc
`[Jai [207302880088
`5°
`2013-07-11
`Fresenius Medical Care
`
`2013-07-11
`no
`[5 2073708806
`no
`2013-08-08
`[ae Jatt 1408907
`no
`2073-08-22
`[fas [aot stat ean
`no
`2014-08-07
`Pas fear arate
`no
`2014-08-07
`[ar__faoraraties
`no
`2014-08-07
`[Yas faoratatie7
`no
`2014-08-07
`[a8 fear araties
`no
`2011-08-31
`[[0200858
`no
`3
`2100555A1
`2008-09-76
`5°
`2013-04-24
`
`Fresenius Medical Care
`
`555
`
`—
`
`2010-12-09
`
`2011-12-01
`
`1987-11-06
`
`Fresenius Medical Care
`Holdings, Inc., Technion
`
`Research and Development Foundation, Ltd.
`
`Baxter International Inc.,
`Baxter Healthcare S.A.
`Asahi Kasei Kogyo
`Kabushiki Kaisha
`
`5°
`
`no
`
`5°
`
`
`
`TOTS
`BETO
`no
`2701596
`Zora 11-0
`no
`2701596
`2014-08-05
`no
`5009464
`2012-10-08
`no
`
`
`feo [9937342 fosoro2|CS no
`2°SsoO
`EP 1281351
`Galley
`no
`5°
`EP2719406B1
`Nikkiso CompanyLimited
`2016-05-25
`n
`=i[uP 863-149077
`1987-11-20
`o];o
`
`P(e|w02072148788 Al 2012-11-01 n
`
`p85] WO2013022760A1[KupferPfnT[None] 2011-08-05
`
`
`
`
`
`Page 6/11
`
`

`

`
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`
`
`
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`
`
`
`
`[Jas [woanrs0er2aTat [Nene|____ [2075-0604
`
`Examiner
`Initial
`
`i
`
`.
`
`Se TPLISSWOU3
`
`
`[FF RPPOTTuSanaT0aeratonalSartporWhenOpinaiedMaa@-2D16 Yo
`
`WANG, Fundamentals of intrathoracic impedance monitoring in heart failure, Am. J. Cardiology, 2007, 3G-10G: Suppl.
`
`[Fre NPL LEVER,taKaryapzpzaeeaTgteerator Je 205:
`
`
`
`
`
`
`eeee BLEYER,ET. AL., Sudden and cardiac death rated in hemodialysis patients, KidneyInternational. 1999, 1553-1559: 55. ino|
`
`
`
`
`P20 INPL187]PCT/US2012/034333,PreliminaryReportonPatentability,October29,2013ntIntemational
`
`
`
`
`
`
`[faifinpra8|PCT70820121084888,InlemationalSearchReport,August29,2012roJ
`
`
`
`P22INPL188]IntemationalSearchReport,August29,2013ftPCT/US2012/034333,
`
`
`
`
`
`
`_______128_]INPLTOZ7)PreliminaryReportonPatentability,Oetober29,2073____{ro|POTIUS2072/034980, International
`
`NON-PATENTLITERATURE DOCUMENTS
`Include name of the author (in CAPITAL LETTERS),title of the article (when appropriate), title of the
`|item(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`publisher, city and/or country where published.
`PL105] BRYNDA,ET. AL., The detection of toman 2-microglcbuiin by grating coupler immunosensor with three dimensional antibody
`tworks. Biosensors & Bioelectronics, 1999, 363-368, 14(4).
`PL10] WHEATON, et al., DOWEX ION EXCHANGE RESINS-FUNDAMENTALS OF ION EXCHANGE; June 2000, pp. 1-9.
`p:/Awww.dow.com/scripts/litorder.asp ?filepath=liquidseps/pdfs/noreg/177-01837.pdf
`PL111] ZHONG, ET. AL., Miniature urea sensor based on H(+)-ion sensitive field effect transistor and its application in clinical analysis, Chin.
`J. Biotechnol., 1992, 57-65. 8(1)
`
`
`|__| [InPt19}Por7us2072/034361, InternationalSearchReportandWritenOpiniondatedJuly9,2072———SSSSS—~i|
`
`
`
`
`
`
`
`|___[6__[INPL127]ROBERTSM,TheregenerativesorbentNephrology,1998,275-2764,system.dialysis (REDY) Sidr]
`
`
`|_____[__[INPL138|USProvisionalApplicationNo.61480544SSSCSCSCSCSCSCC*SdON
`
`
`|___[7__[INPL739}USProvisional 61/480,641datedApri@0,2071ro]Application No.
`
`
`rs [no|NPL142] Hemametrics, Crit-Line Hematocrit Accuracy, 2003, 1-5, Vol. 1, Tech Note No. 11 (Rev. D).
`
`NPL144] Weissman, S., et al., Hydroxyurea-induced hepatitis in human immunodeficiency virus-positive patients. Clin. Infec. Dis, (1999 July
`29): 223-224.
`
`
`
`P|10INPL146]IntemationalSearchReport,July6,2012ftPCT/US2012/034334,
`
`
`
`
`P__ [11__JINPL147}PCT/US2012/034836,IntemationalSearchRepor,September,012SSSSCSCSCSCSCSCSCSCSCSCSCSCSCSC~*dO_
`
`
`
`p12INPL148]InternationalSearchReport,August13,2013ntPCT/US/2012/034327,
`
`
`fS«*13[INPL149] PCT/US/2012/034329,International Search Report, December 3, 2012 [no|no
`14
`NPL14] FOLEY,et al., Long Interdialytic Interval and Martality among Patients Receiving Hemodialysis, N Engl Jrnl Med.
`201 1:365(12):1099-1107
`NPL15] PCTInternational Search Report from International Application number PCT/US2014/067650, dated November 27, 2013, docket
`
`
`
`
`
`
`NPL205] CULLETON, BF etal. Effect of Frequent Nocturnal Hemodialysis vs. Conventional Hemodialysis on Left Ventricular Mass and Quality|no
`of Life. 2007 Journal of the American Medical Association 298 (11), 1291-1299
`
`
`p25INPL217]USAppl. 2/1/2013, (Atty.DocketC00004928.USU1)mt13/757,722, filed
`
`
`
`
`
`
`P__[26__|INPL218]USAppl.18/757,794,fled272/202,(Atty.Docketcooooa4a7.USU2)SSSSSCSCSCSCSCSCSCSCSC~SO_
`
`
`
`
`
`
`|27INPL218]USAppl.13/791,755,filed3/8/2013(AttyDocketCo0004970.USU2)mt
`
`
`
`p28INPL21]USPat.App.19/424,479datedNovember1,20120nt
`
`
`
`
`
`P___[29__|INPL220]USAppl.18/757,792,fled2/2/2018(AttyDocketCOO0DMSBUSUA)SSSSCSCSCSCSCSCSCSCSCSCSC*dCO_
`
`
`
`
`
`
`P80INPL222]USAppl.13/757,794,filed2/2/2013(AttyDocketC00004437.USU2)_mt
`
`
`ptINPL227]USAppl.13/837,287,filed3/15/2013no
`|«82 INPL22] US Pat. App. 13/424,429 dated November1, 2012
`33
`NPL230] REDFIELD, ET. AL, Restoration of renal responseto atria! natriuretic factor in experimental low-output heatfailure, Am. J. Physiol.,
`
`P| Oct 1, 1989, R917-923:257. re|
`
`aa
`"|
`
`P| Sensors, August 24, 2009, 6613-8625,9 re|
`
`
`
`34 PL231] ROGOZA,ET. AL., Validation of A&D UA-767 device for the self-measurement of blood pressure, Blood Pressure Monitoring, 2000,|no
`
`35
`
`36
`
`PL234] LIMA, ET. AL., An electrochemical sensor based on nanostructure hollsndite-type manganese oxide for detection of potassium ion,
`
`no
`
`PL235] MACLEAN, ET, AL., Effects of hindlimb contraction on pressor and muscle interstitial metabolite responsesin the cat, J. App.
`Physiol., 1998, 1583-1592, 85(4)
`
`Page 7/11
`
`

`

`
`
`
`°S])5)];53555555S/535°
`
`NPL26] OVERGAARD, ET. AL., Activity-induced recovery of excitability in K+-depressed rat soleus muscle, Am. J. P 280: R48-R55, Jan 1,
`2001.
`PL27] OVERGAARD. ET. AL., Relations between excitability and contractility in rate soleusmuscle: role of the NA+-K+ pump and NA+-K-S
`gradients. Journal of Physiology, 1999, 215-225, 518(1).
`PL306] COAST, ET AL. 1990, An approach to Cardiac Arrhythmia analysis Using Hidden Markov Models, IEEE Transactions On Biomedical
`gineering. 1990, 37(9):826-835.
`NPL309] WEINER, ET. AL., Article: Cardiac Function and Cardiovascular Disease in Chronic Kidney Disease, Book: Primer on Kidney
`Diseases (Author: Greenberg, et al), 2009,499-505, 5th Ed., Saunders Elsevier, Philadelphia, PA.
`PL310] US Provisional Pat. App. No,: 61/480,532
`PL311] US Pat. App. No.: 13/424,479
`PL312] US Pat. App. No: 13/424,429 dated November 1, 2012
`PL313] US Pat. App. No: 13/424,525
`PL317] US Provisional Pat. App. No.: 61/480,530
`PL318] US Provisional Pat. App. No.: 61/480,528 dated April 29, 2011
`PL328] GENOVESI, et al., Nephrology, Dialysis, Transplantation 2009; 24(8):2529-2536
`PL32] SECEMSKY,ET. AL, High prevalence of cardiac autonomic dysfunction and T-wave alternansin dialysis patients. Heart Rhythm, April
`11, 592-598 : Vol. 8, No. 4.
`PL35] WEI, ET. AL., Fullerene-cryptand coated piezoelectric crystal urea sensor based on urease, Analytica Chimica Acta, 2001 ,77-85:437.
`PL376] Gambro AK 96 Dialysis Machine Operators Manual, December 2012. p. 1-140
`NPL37] US NonProvisional Application, Ser. No.: 13/368,225 dated February 7, 2012
`PL383] LEIFER et al., A Study on the Temperature Variation of Rise Velocity for Large Clean Bubbles, J. Atmospheric & Oceanic Tech., Vol.
`, Pp 1392-1402, Oct 2000
`PL384] TALAIA, Terminal Velocity of a Bubble Rise in a Liquid Column, World Acad. of Sci., Engineering & Tech., Vol. 28, pp. 264-68,
`blished 1/1/2007
`PL386] The FHN Trial Group. In-Center. Hemodialysis Six Times per Week versus Three Times per Week, New England Journal of
`Medicine, 2010 ABSTRACT
`NPL39] PCT/US2012/034332, International Search Report, July 5, 2012
`PL46] SIEGENTHALER, et al., Pulmonary fluid status monitoring with intrathoracic impedance, Journal of Clinical Monitoring and Computing,
`24:449-451, published 12 January 2011
`
`5°
`
`
`S])5)];53Sy/5];5
`
`
`
`
`SyjsSys5/sS/5o]o];oo];/oO]oO/OTO}/O/10
`
`5°
`
`5°
`
`5°
`5°
`5°
`
`aS)55
`
`O];/O];/OToO
`
`Zz
`N
`
`N N N N
`
`PL55] US Pat. App. 13/424,454
`PL57] US Pat. App.: 13/424,467
`PL62] US Pat, App.: 13/424,533
`PL632] Lakerveld et al, Primary prevention of diabetes mellitus type 2 and cardiovascular diseases using a cognitive behavior program aimed
`lifestyle changes in people at risk: Design of a randomized controlledtrial, 2008, BMC Endocrine Disorders, 8(6): 1-19
`t
`NPL633] Gordhandaset al, Real-Time Extraction and Analysis of Key Morphological Features in the Electrocardiogram, for Data Compression
`and Clinical Decision Support, 2004, Computational Physiology, pp. 15-18
`
`
`
`INFORMATION DISCLOSURE
`
`Filing Date
`
`2019-05-14
`
`Application Number
`
`16411508
`
`First Named Inventor
`
`Roettger
`
`STATEMENT BY APPLICANT
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`NPL23] US Pat. App. 13/424,525
`
`Pd
`
`
`aS)5
`
`Sy]5S];3];5o]o];oO;/O];/OTO/o
`
`5°
`
`5°
`
`Sco~oayaojcaycayonoyoycaoO~™aewo=«]CoNI]O]or]&NM}+|ooglwo
`
`fon)OonN
`
`oD
`RDol
`
`o
`
`I]NI]SIN~oi]BR]oyNM+
`
`~o
`
`°|—
`
`NPL90] NEDELKOV, ET. AL., Design of buffer exchange surfaces and sensor chips for biosensor chip mass spectrometry, Proteomics, 2002,
`1-446, 2(4).
`——s—«'77] [NPL] European Search Report App 14865374.4, June 12, 2017
`|«78|[NPL] European Search Report for Application No. 14865128 .4 dated June 20, 2017
`
`Page 8/11
`
`

`

`INFORMATION DISCLOSURE.
`
`[Filing pate
`
`2019-05-14
`
`Application Number
`
`16411508
`
`
`
`
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`|———s«d79 [NPL] GREENetal., Sudden Cardiac Death in Hemodialysis Patients: an In-Depth Review , Am J Kidney Dis 57(6)921:929 [no|
`
`[NPL] RAJAN et al. Generalized Feature Extraction for Time-Varying Autoregressive Models, IEEE Transacion Signal Processing VOL. 44, NO.
`10
`|«81 Chinese Office Action in App. No. 201480059332.5, Dated March 30, 2018 no
`
`|«82s|EP. OAfor App. No. 16709165.1 dated October 22, 2019
`
`a European Search Report forApp. No. 14859115.9, dated January5, 2018
`
`oT]
`
`Include copy of this form with next communication to applicant.
`
`Laurent, Jeanpierre, "Continuous Monitoring of Dynamic Systems: Application to Monitoring of Dialyzed Patients" October 30, 2004, received
`from internet: http://laurent.jeanpierre| .free.fr/recherche/papiers/aista2004.pdf
`|«85|PCT/US2016/058579International Search Report dated January 31, 2017
`|«86s PCT/US2016/058579_WO
`
`EXAMINER SIGNATURE
`
`|ExaminerSignature[|0 Date Considered
`*EXAMINER: Initial if reference considered, whetheror not citation is in conformance with MPEP 609. Drawline through a citation if not in conformance and not considered.
`
`Page 9/11
`
`

`

`
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`CERTIFICATION STATEMENT
`That each item of information contained in the information disclosure statement wasfirst cited in any communication from a foreign patent office ina
`counterpart foreign application not more than three monthsprior to thefiling of the information disclosure statement. See 37 CFR 1.97(e}(1).
`
`That no item of information contained in the information disclosure statement was cited in a communication from a foreign patentoffice in a
`counterpart foreign application, and, to the knowledge of the person signing the certification after making reasonable inquiry, no item of information
`contained in the information disclosure statement was knownto anyindividual designated in 37 CFR 1.56(c) more than three months priorto the filing
`of the information disclosure statement. See 37 CFR 1.97(e)(2).
`
`:Signature{Roger©RayDate (YYYY-MM-DD
`
`Registration Number
`
`See attachedcertification statement
`A certification statement is not submitted herewith
`
`|i Thefee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`SIGNATURE
`
`Name/Print
`
`Page 10/11
`
`

`

`INFORMATION DISCLOSURE.
`
`[Filing pate
`
`2019-05-14
`
`Application Number
`
`16411508
`
`
`
`
`
`STATEMENT BY APPLICANT[ExaminerName|ZALUKAEVA, TATYANA
`
`aware of a violation or potential violation of law or regulation.
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552) and the Privacy Act
`(5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine whether the Freedom of Information Act
`requires disclosure of these record s.
`2. Arecord from this system of records may bedisclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or administrative
`tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a requestinvolving an individual, to whom
`the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of the record.
`4. A record in this system of records maybe disclosed, as a routine use, to a contractor of the Agency having needfor the information in order to perform
`a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C.
`552a(m).
`5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed, as a routine use,
`to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security review (35 U.S.C.
`181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee, during an
`inspection of records conducted by GSAaspart of that agency's responsibility to recommend improvements in records managementpractices and
`programs, underauthority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSAregulations governing inspection of
`records for this purpose, and any otherrelevant(i.e., GSA or Commerce) directive. Such disclosure shall not be used to make determinations about
`individuals.
`8. A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant to 35 U.S.C.
`122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use,
`to the public if the record wasfiled in an application which became abandonedorin which the proceedings were terminated and which application is
`referenced byeither a published application, an application open to public inspections or an issued patent.
`9. A record from this system of records may bedisclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the USPTO becomes
`
`Attorney Docket Number
`
`|C00012299US01DIV(MED-2910
`
`Privacy Act Statement
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to a
`patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection of this
`information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by
`the U.S. Patent and TrademarkOffice is to process and/or examine your submission related to a patent application or patent. If you do not furnish the
`requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which mayresult in termination
`of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`Page 11/11
`
`